The cystic fibrosis gender gap: Potential roles of estrogen

Pediatric Pulmonology

Volumn 49, Issue 4, 2014, Pages 309-317

  Sweezey, Neil B ^a   Ratjen, Felix ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

estradiol; inflammation; mortality; sex hormone; survival

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ESTROGEN; SEX HORMONE;

CYSTIC FIBROSIS; DISEASE COURSE; GENDER; GENDER GAP; HUMAN; ION TRANSPORT; LUNG FIBROSIS; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; COMPLICATION; FEMALE; INFLAMMATION; MALE; PHYSIOLOGY; SEX DIFFERENCE; SURVIVAL RATE;

CYSTIC FIBROSIS; DISEASE PROGRESSION; ESTROGENS; FEMALE; HUMANS; INFLAMMATION; MALE; SEX FACTORS; SURVIVAL RATE;

EID: 84896404409     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22967     Document Type: Review

References (64)

1. Davis PB,. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173: 475-482.
2. Corey M, Farewell V,. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017.
3. Ratjen F, Doring G,. Cystic fibrosis. Lancet 2003; 361: 681-689.
4. Davies JC, Griesenbach U, Alton E,. Modifier genes in cystic fibrosis. Pediatr Pulmonol 2005; 39: 383-391.
5. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B,. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803.
6. Davis PB,. The gender gap in cystic fibrosis survival. J Gend Specif Med 1999; 2: 47-51.
7. Stern M, Wiedemann B, Wenzlaff P, German Cystic Fibrosis Quality Assessment Group. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995-2006. Eur Respir J 2008; 31: 29-35.
8. Viviani L, Bossi A, Assael BM, Italian Registry for Cystic Fibrosis Group. Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age. J Cyst Fibros 2011; 10: 313-317.
9. Verma N, Bush A, Buchdahl R,. Is there still a gender gap in cystic fibrosis ? Chest 2005; 128: 2824-2834.
10. Urquhart DS, Thia LP, Francis J, Prasad SA, Dawson C, Wallis C, Balfour-Lynn IM,. Deaths in childhood from cystic fibrosis: 10-year analysis from two London specialist centres. Arch Dis Child 2013; 98: 123-127.
11. Griesenbach U, Baty NJ, Cullinan P, Alton EW, Bilton D, MacNeill SJ,. Gender differences in the UK CF population. Pediatr Pulmonol 2012; 47: 385, Abstract 444.
12. Harness-Brumley CL, Elliott A, Rosenbluth DB, Jain R,. The risk of female gender on survival in cystic fibrosis. Pediatr Pulmonol 2012; 47: 298-299, Abstract 216.
13. Corey M, Edwards L, Levison H, Knowles M,. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997; 131: 809-814.
14. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139, 139.e1.
15. Zhang Z, Shoff SM, Lai HJ,. Occurrence of cystic-fibrosis related diabetes by age 20 years is associated with impaired pubertal linear growth. Pediatr Pulmonol 2012; 47: 409-410, Abstract 507.
16. Kernan NG, Alton EW, Cullinan P, Griesenbach U, Bilton D,. Oral contraceptives do not appear to affect cystic fibrosis disease severity. Eur Respir J 2013; 41: 67-73.
17. Henry RL, Mellis CM, Petrovic L,. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992; 12: 158-161.
18. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005; 293: 581-588.
19. Gibson RL, Burns JL, Ramsey BW,. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951.
20. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP,. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000; 407: 762-764.
21. Chotirmall SH, Smith SG, Gunaratnam C, Cosgrove S, Dimitrov BD, O'Neill SJ, Harvey BJ, Greene CM, McElvaney NG,. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med 2012; 366: 1978-1986.
22. Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ,. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 2005; 49: 2921-2927.
23. Bals R,. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-150.
24. Bals R, Weiner DJ, Meegalla RL, Wilson JM,. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 1999; 103: 1113-1117.
25. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G,. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006; 306: 153-182.
26. Wright JM, Merlo CA, Reynolds JB, Zeitlin PL, Garcia JG, Guggino WB, Boyle MP,. Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. Am J Respir Cell Mol Biol 2006; 35: 327-336.
27. Singh PK, Parsek MR, Greenberg EP, Welsh MJ,. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 552-555.
28. Wang Y, Cela E, Gagnon S, Sweezey NB,. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res 2010; 11: 166.
29. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton TA, Eidelman DH, Stevenson MM, Radzioch D,. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002; 107: 297-305.
30. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M,. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
31. Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, Clement A,. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 1999; 14: 339-346.
32. Cantin A,. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995; 151: 939-941.
33. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW,. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
34. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW,. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001; 32: 356-366.
35. Hirota K, Martin B, Veldhoen M,. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 2010; 32: 3-16.
36. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC,. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011; 184: 252-258.
37. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, Pirhonen J, Kolls JK,. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175: 404-412.
38. Dubin PJ, McAllister F, Kolls JK,. Is cystic fibrosis a TH17 disease ? Inflamm Res 2007; 56: 221-227.
39. Dubin PJ, Kolls JK,. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007; 292: L519-L528.
40. D'Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, Farruggio R, Miceli DM, Miele M, Castagnetta L, Cillari E,. Sex hormones modulate inflammatory mediators produced by macrophages. Ann NY Acad Sci 1999; 876: 426-429.
41. Angele MK, Knöferl MW, Shwacha MG, Ayala A, Cioffi WG, Bland KI, Chaudry IH,. Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol 1999; 277: C35-C42.
42. Clarke LA, Sousa L, Barreto C, Amaral MD,. Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies. Respir Res 2013; 14: 38.
43. Straub RH,. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-574.
44. Verthelyi D, Klinman DM,. Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 2000; 100: 384-390.
45. Adori M, Kiss E, Barad Z, Barabás K, Kiszely E, Schneider A, Kövesdi D, Sziksz E, Abrahám IM, Matkõ J, Sármay G,. Estrogen augments the T cell-dependent but not the T-independent immune response. Cell Mol Life Sci 2010; 67: 1661-1674.
46. Whitacre CC, Reingold SC, O'Looney PA,. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
47. Khan D, Dai R, Karpuzoglu E, Ahmed SA,. Estrogen increases, whereas IL-27 and IFN-gamma decrease, splenocyte IL-17 production in WT mice. Eur J Immunol 2010; 40: 2549-2556.
48. Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA,. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 2005; 73: 3693-3701.
49. Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV, Ward PA,. Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol 2005; 288: C881-C890.
50. Chotirmall SH, Greene CM, Oglesby IK, Thomas W, O'Neill SJ, Harvey BJ, McElvaney NG,. 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med 2010; 182: 62-72.
51. Anderson HR, Pottier AC, Strachan DP,. Asthma from birth to age 23: incidence and relation to prior and concurrent atopic disease. Thorax 1992; 47: 537-542.
52. Mandhane PJ, Greene JM, Cowan JO, Taylor DR, Sears MR,. Sex differences in factors associated with childhood- and adolescent-onset wheeze. Am J Respir Crit Care Med 2005; 172: 45-54.
53. Stanford KI, Mickleborough TD, Ray S, Lindley MR, Koceja DM, Stager JM,. Influence of menstrual cycle phase on pulmonary function in asthmatic athletes. Eur J Appl Physiol 2006; 96: 703-710.
54. Barr RG, Camargo CA Jr., Hormone replacement therapy and obstructive airway diseases. Treat Respir Med 2004; 3: 1-7.
55. Cooke A,. Th17 cells in inflammatory conditions. Rev Diabet Stud 2006; 3: 72-75.
56. Talal N,. Natural history of murine lupus. Modulation by sex hormones. Arthritis Rheum 1978; 21 (5 Suppl): S58-S63. Review.
57. Boucher RC,. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002; 54: 1359-1371.
58. Sweezey N, Tchepichev S, Gagnon S, Fertuck K, O'Brodovich H,. Female gender hormones regulate mRNA levels and function of the rat lung epithelial Na channel. Am J Physiol 1998; 274: C379-C386.
59. Sweezey NB, Gauthier C, Gagnon S, Ferretti E, Kopelman H,. Progesterone and estradiol inhibit CFTR-mediated ion transport by pancreatic epithelial cells. Am J Physiol 1996; 271: G747-G754.
60. Sweezey NB, Ghibu F, Gagnon S,. Sex hormones regulate CFTR in developing fetal rat lung epithelial cells. Am J Physiol 1997; 272: L844-L851.
61. Sweezey NB, Smith D, Corey M, Ellis L, Carpenter S, Tullis DE, Durie P, O'Brodovich HM,. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis. Pediatr Pulmonol 2007; 42: 519-524.
62. Fanelli T, Cardone RA, Favia M, Guerra L, Zaccolo M, Monterisi S, De ST, Riccardi SM, Reshkin SJ, Casavola V,. Beta-oestradiol rescues DeltaF508CFTR functional expression in human cystic fibrosis airway CFBE41o- cells through the up-regulation of NHERF1. Biol Cell 2008; 100: 399-412.
63. Boucher RC, Cheng EH, Paradiso AM, Stutts MJ, Knowles MR, Earp HS,. Chloride secretory response of cystic fibrosis human airway epithelia. Preservation of calcium but not protein kinase C- and A-dependent mechanisms. J Clin Invest 1989; 84: 1424-1431.
64. Coakley RD, Sun H, Clunes LA, Rasmussen JE, Stackhouse JR, Okada SF, Fricks I, Young SL, Tarran R,. 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest 2008; 118: 4025-4035.